Works matching IS 11732563 AND DT 2023 AND VI 43 AND IP 9
Results: 8
Effectiveness of Calcitonin Gene-Related Peptide Monoclonal Antibodies in the Prevention of Migraine: A Systematic Review and Meta-Analysis of Observational Cohort Studies.
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 9, p. 669, doi. 10.1007/s40261-023-01301-7
- By:
- Publication type:
- Article
OCE-205, A Novel, Selective Vasopressin Receptor Mixed Agonist-Antagonist: Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics from a Phase 1 Study in Healthy Volunteers.
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 9, p. 709, doi. 10.1007/s40261-023-01299-y
- By:
- Publication type:
- Article
Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate.
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 9, p. 699, doi. 10.1007/s40261-023-01294-3
- By:
- Publication type:
- Article
Correction: Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Real-World Safety and Effectiveness of Controlled-Release Cilostazol in Patients with Symptomatic Peripheral Artery Disease.
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 9, p. 729, doi. 10.1007/s40261-023-01302-6
- By:
- Publication type:
- Article
Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis.
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 9, p. 681, doi. 10.1007/s40261-023-01282-7
- By:
- Publication type:
- Article
Efficacy, Safety, and Systemic Exposure of Once-Daily Indacaterol Acetate in Pediatric Asthma: A Randomized, Double-Blind, Controlled Dose-Finding Study.
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 9, p. 719, doi. 10.1007/s40261-023-01300-8
- By:
- Publication type:
- Article
Anthracyclines versus No Anthracyclines in the Neoadjuvant Strategy for HER2+ Breast Cancer: Real-World Evidence.
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 9, p. 691, doi. 10.1007/s40261-023-01291-6
- By:
- Publication type:
- Article